Carmen Peral
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Potential implications of increased utilization of oral nirmatrelvir/ritonavir in outpatient care for COVID-19: modeled findings from the Spanish National Health System perspective.
Journal: Journal of medical economics
Published: June 13, 2026
Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 04, 2025
Prevalence, disability, and economic impact of migraine in Spain: a nationwide population-based study.
Journal: The journal of headache and pain
Published: March 24, 2025
Cost analysis of transthyretin amyloid cardiomyopathy in heart failure patients with preserved ejection fraction in Spain.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: February 05, 2025
Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain.
Journal: Journal of medical virology
Published: November 28, 2024
Real-world psychosocial impact among patients with juvenile idiopathic arthritis and families in Spain.
Journal: Pediatric rheumatology online journal
Published: January 11, 2024
Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study.
Journal: Journal of health economics and outcomes research
Published: October 23, 2023
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency.
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 24, 2023
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
Journal: Journal of health economics and outcomes research
Published: April 28, 2023
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: October 07, 2021
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 28, 2021
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 16, 2021
Last Updated: 09/26/2026